MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Effect of Deep Brain Stimulation on the Motor Profile of Parkinson’s Disease in Egypt; A Developing Country Experience

    S. Abdelaziz, A. Shalash, E. Hamid, Z. Yossry, M. Alkarras, D. Elheraby, Y. Salah, M. Essam, H. Radwan (Cairo, Egypt)

    Objective: To identify the effect of DBS of bilateral STN or bilateral GPi on different motor parameters of PD Background: Deep brain stimulation (DBS) of…
  • 2023 International Congress

    Suicidal ideation and suicide risk in Parkinson’s disease

    J. Lam, X. Tang, D. Meng, J. Zhu, P. Uzelman, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To examine the prevalence of suicidal ideation and suicide risk in patients with Parkinson’s disease (PD) and to assess the relationship between suicidal ideation…
  • 2023 International Congress

    Sex differences in motor response to levodopa in early Parkinson’s disease

    M. Gevertzman, A. Hooyman, J. Longhurst, M. Landers (Las Vegas, USA)

    Objective: To evaluate differences between males and females in trajectory of motor response to levodopa in early Parkinson’s disease (PD). Background: Previous research has shown…
  • 2023 International Congress

    From the Healthy Brain Ageing – HeBA – Cohort: Motivation for participating in the first online phase of HeBA

    P. Mahlknecht, T. Marques, C. Vega Moreno, C. Horlings, A. Garrido, S. Schade, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Seppi, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krueger, B. Mollenhauer, M. Marti (Innsbruck, Austria)

    Objective: We aim to understand the motivation of participants to join the first online-phase of the European multicenter Healthy Brain Ageing (HeBA; see Abstract 0748_1125_001612)…
  • 2023 International Congress

    Habenula Volume in Mood Disorders in Parkinson’s Disease

    B. Samanci, Y. Temel, M. Kuijf, S. Tan, S. Michielse (Maastricht, Netherlands)

    Objective: To assess whether dysregulation of habenula (Hb) contributes to mood disorders in Parkinson’s disease (PD). Background: PD is often accompanied by mood disorders, such…
  • 2023 International Congress

    SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models

    M. Castelo, G. Gentile, A. Zanon, A. Lavdas, C. Bolduc, M. Picon, S. Laouafa, J. Soliz, M. Lévesque, I. Pichler (Bolzano, Italy)

    Objective: Validate the rescue potential of SLP-2 induction for α-synuclein (aSyn)-induced mitochondrial pathology and neurodegeneration in two complementary models: human induced pluripotent stem cell (hiPSC)-derived…
  • 2023 International Congress

    Retrospective exploration of the 5-2-1 criteria in clinical practice

    M. Karlstedt, A. Johansson (Stockholm, Sweden)

    Objective: To explore documentation in medical records (EMRs) of the 5 (5 oral levodopa doses taken/day) -2 (2hours of OFF time/day) -1 (1 hour of…
  • 2023 International Congress

    Continuous algorithmic insights into PD motor symptoms and individual treatment response

    M. Sander, FMJ. Pfister, G. Höglinger, J. Levin, A. Ceballos-Baumann, UM. Fietzek (Munich, Germany)

    Objective: To quantify the short-duration levodopa response using high resolution data derived from a wrist sensor and processed with advanced deep learning methods Background: The…
  • 2023 International Congress

    A human tissue engineered nigrostriatal system as a testbed for understanding PD pathophysiology and therapeutic development

    D. Chouhan, K. Browne, R. Patel, S. Karandikar, F. Laimo, D. Cullen, J. Duda (Philadelphia, USA)

    Objective: The objective of these studies is to develop a tissue engineered nigrostriatal system involving human dopaminergic and striatal cells to recapitulate many of the…
  • 2023 International Congress

    The effect of dopaminergic medication on force fluctuation in Parkinson’s disease

    B. Afsharipour, M. Schindle, F. Roy, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify and compare muscle force variability during isometric dorsiflexion in male patients with Parkinson's Disease (PD), in the ON- versus OFF-medication state. Background:…
  • « Previous Page
  • 1
  • …
  • 164
  • 165
  • 166
  • 167
  • 168
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley